Randomized phase 3, multicenter, open-label study comparing evofosfamide (Evo) in combination with doxorubicin (D) vs. D alone in patients (pts) with advanced soft tissue sarcoma (STS): Study TH-CR-406/SARC021 Meeting Abstract
| Authors: | Tap, W.; Papai, Z.; van Tine, B.; Attia, S.; Ganjoo, K.; Jones, R. L.; Schuetze, S.; Reed, D.; Chawla, S. P.; Riedel, R.; Krarup-Hansen, A.; Italiano, A.; Hohenberger, P.; Grignani, G.; Cranmer, L.; Alcindor, T.; Lopez-Pousa, A.; Pearce, T.; Kroll, S.; Schoffski, P. |
| Abstract Title: | Randomized phase 3, multicenter, open-label study comparing evofosfamide (Evo) in combination with doxorubicin (D) vs. D alone in patients (pts) with advanced soft tissue sarcoma (STS): Study TH-CR-406/SARC021 |
| Meeting Title: | 41st European Society for Medical Oncology Congress (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 27 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2016 Oct 7-11 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2016-10-01 |
| Start Page: | vi483 |
| Language: | English |
| ACCESSION: | WOS:000393913000482 |
| DOI: | 10.1093/annonc/mdw388.01 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1395O -- Source: Wos |
